SNT syntara limited
Add to My Watchlist 14.9% ! 5.7¢

Value of Syntara, page-89

  1. jtsmith439
    87 Posts.
    lightbulb Created with Sketch. 10
    clock Created with Sketch.
    05/06/25
    20:46
    Post #: 79336754
    Dont disagree, much prefer the true biotech fund investors. Their selling is due to withdrawals from the Health Sciences Fund which holds their SNT shares. They have been forced to build their cash to support these redemptions.
    SNT Price at posting: 6.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Pathological Complete Response Recorded in ACCENT Trial of Advanced Pancreatic Cancer
right-arrow Created with Sketch.
NEWS Building Permits Received for Phase One Renewable Power Plant
right-arrow Created with Sketch.
NEWS New Positive Interim Data in Phase 2 Study of SNT-5505 in Myelofibrosis
right-arrow Created with Sketch.
NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)
right-arrow Created with Sketch.
NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
5.7¢ 		Change
-0.010(14.9%) 		Mkt cap ! $92.60M
Open High Low Value Volume
6.7¢ 6.7¢ 5.5¢ $569.7K 9.664M

Buyers (Bids)

No. Vol. Price($)
1 5000 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 468564 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.